Press Releases

Meryl Comer’s Slow Dancing with a Stranger wins 2015 International Book Award

June 2, 2015

Washington, DC – Slow Dancing With a Stranger: Lost and Found in the Age of Alzheimer’s has won the 2015 International Book Award for Autobiography/Memoirs. Meryl Comer, a former Emmy Award winning reporter, producer and talk show host, writes a poignant and deeply personal account of a professional couple in their prime and what happens when her physician husband is diagnosed with early onset Alzheimer’s disease at age 58. On the bestseller lists of the New York Times

Global Alzheimer’s Platform and Innovative Medicines Initiative to Sign Memorandum of Understanding to Accelerate Alzheimer’s Drug Development

March 19, 2015

Nice, France -- The Global Alzheimer’s Platform (GAP) and the Innovative Medicines Initiative (IMI) announced today that they will sign a Memorandum of Understanding (MOU) to accelerate Alzheimer’s drug development by building a global, standing, trial-ready platform for Alzheimer’s drug development. The collaboration represents a significant commitment to work together to recruit patients for clinical trials, to create a high-performing clinical trial system, and to develop a standing adaptive protocol to test new molecules quickly, and move those with promise into

CEOi Applauds New $100 Million Global Dementia Discovery Fund

March 17, 2015

Geneva, Switzerland – Following is a statement by George Vradenburg, convener of the Global CEO Initiative (CEOi) on Alzheimer’s Disease, on today’s announcement by UK Health Secretary Jeremy Hunt that more than $100 million has been raised to support the Dementia Discovery Fund. The fund, which was created by the British government, is unique because it is bringing together government and industry to on a single disease – dementia.

USAgainstAlzheimer’s Urges HHS Secretary Burwell to Attend the World Health Organization First-Ever Ministerial Meeting on Dementia

March 11, 2015

Washington, DC – USAgainstAlzheimer’s, an innovative and transformational organization demanding greater urgency in the fight against Alzheimer's disease and dementia, today called on Health and Human Services Secretary Sylvia Mathews Burwell to attend the World Health Organization (WHO) First Ministerial Meeting on Dementia. The meeting, to which the health ministers of 62 nations are invited, will be held on March 16 and 17 in Geneva, Switzerland.

Global CEO Initiative on Alzheimer’s Disease (CEOi) Launches Program to Harness Power of Big Data, Accelerating Pace of Alzheimer’s Research

February 25, 2015

Health care research and innovation collaborative Optum Labs selected as primary research partner

Washington, DC – The Global CEO Initiative on Alzheimer’s Disease (CEOi) has developed an innovative research initiative with the potential to bring new evidence and innovation to public and private research agendas aimed at redefining care delivery and changing the way future generations are affected by Alzheimer’s disease.

Why 2020?

UsAgainstAlzheimer’s has retained its goal of stopping Alzheimer’s by 2020 rather than endorsing the goal of the National Plan to Address Alzheimer’s Disease that calls for preventing and effectively treating the disease by 2025. While we support the national plan and its goals, we believe, as most every family touched by Alzheimer’s disease believes, that preventing and effectively treating Alzheimer's by 2025 is simply too long a wait for concrete progress. There are promising avenues of drug discovery and development that will, if successful, deliver a means of slowing or deferring Alzheimer's symptoms by 2020. By voicing the urgency felt by so many families, we will pressure researchers and industry to do all in their power to make that happen.